Skip to main content
. 2016 Jan 26;76:459–483. doi: 10.1007/s40265-015-0534-3

Fig. 1.

Fig. 1

Therapeutic options in NPSLE. aCL anticardiolipin antibodies, β2GP I β2-glycoprotein I, LAC lupus anticoagulant, NPSLE neuropsychiatric systemic lupus erythematosus